In vitro and in vivo evaluation of WAC-224, a novel quinolone class of topoisomerase II inhibitor for cancer therapy

被引：0
|
作者：
Ueshima, Taichi
Yamaguchi, Tomonori
Itoh, Kenji
Kashimoto, Naoki
Hirano, Tatsuya
Shimabara, Rumiko
Kawakubo, Yohei
Sato, Masayuki
Yamashita, Junpei
Yazaki, Akira
Tamura, Koichi
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-5106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5106
引用
收藏
页数：2
相关论文
共 50 条
  • [21] In Vitro and In Vivo Evaluation of the Effectiveness and Safety of Amygdalin as a Cancer Therapy
    El-Ela, Fatma I. Abo
    Gamal, Amr
    Elbanna, Hossny Awad
    ElBanna, Ahmed H.
    Salem, Heba F.
    Tulbah, Alaa S.
    PHARMACEUTICALS, 2022, 15 (11)
  • [22] In-vitro- and In-vivo-evaluation of inhibitor nucleic acid construction for a specific therapy of human bladder cancer
    Kunze, D.
    Fuessel, S.
    Meye, A.
    Wuttig, D.
    Kraemer, K.
    Kotzsch, M.
    Toma, M.
    UROLOGE, 2007, 46 (09): : 1289 - 1289
  • [23] Design, Synthesis and in vitro Anticancer Activity of a Cu(II) Complex of Carminic Acid: A Novel Small Molecule Inhibitor of Human DNA Topoisomerase I and Topoisomerase II
    Das, Piyal
    Jain, Chetan Kumar
    Roychoudhury, Susanta
    Majumder, Hemanta Kumar
    Das, Saurabh
    CHEMISTRYSELECT, 2016, 1 (21): : 6623 - 6631
  • [24] An extract of the herb E Zhu synergizes with the topoisomerase II inhibitor etoposide to kill cancer cells in vitro
    Smith, Jarrod A.
    Schledewitz, Kari
    Mortensen, Luke
    Strom, David
    FASEB JOURNAL, 2007, 21 (06): : A1190 - A1190
  • [25] In vivo preclinical evaluation of the topoisomerase I inhibitor camptothecin in human triple negative breast cancer xenografts
    Nemati, F.
    Dieras, V.
    de Plater, L.
    Berniard, A.
    Assayag, F.
    Elbaz, C.
    Fontaine, J. J.
    Vincent-Salomon, A.
    Marangoni, E.
    Decaudin, D.
    EJC SUPPLEMENTS, 2010, 8 (05): : 39 - 39
  • [26] Preliminary in vitro and in vivo evaluation of a theranostic radiolabeled PARP inhibitor for ovarian cancer
    Johnson, Taylor
    Mixdorf, Jason
    Barnhart, Todd
    Aluicio-Sarduy, Eduardo
    Patankar, Manish
    Hoffman, Sabrina
    Jeffery, Justin
    Peikin, Justin
    Engle, Jonathan
    Ellison, Paul
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [27] Pharmacological assessment of Ru(II) complex with GidA protein- A novel topoisomerase II inhibitor towards cancer therapeutics
    Infanta, Antony K. Teresa S.
    Durairaju, Nisshanthini
    Raja, Senthil
    Murugesan, Thandeeswaran
    Dhanapal, Anand Raj
    Natarajan, Karupannan
    Balakrishnan, Ajithkumar
    Vedagiri, Hemamalini
    Muthusamy, Palaniswamy
    Jayaraman, Angayarkanni
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (09): : 4143 - 4153
  • [28] In vivo and in vitro evaluation of class II composite resin restorations with different matrix systems
    Cenci, MS
    Lund, RG
    Pereira, CL
    de Carvalho, RM
    Demarco, FF
    JOURNAL OF ADHESIVE DENTISTRY, 2006, 8 (02): : 127 - 132
  • [29] In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer
    Mark Chien
    Mary Astumian
    David Liebowitz
    Carrie Rinker-Schaeffer
    Walter M. Stadler
    Cancer Chemotherapy and Pharmacology, 1999, 44 : 81 - 87
  • [30] In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer
    Chien, M
    Astumian, M
    Liebowitz, D
    Rinker-Schaeffer, C
    Stadler, WM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (01) : 81 - 87
12345